Research Article
Antiatherosclerotic Potential of Clopidogrel: Antioxidant and Anti-Inflammatory Approaches
Table 2
Change in mean plasma levels of hs-CRP, MDA, and GSH in normal control (NC), atherogenic control (AC), vehicle control (VC), and clopidogrel treated groups.
| |||||||||||||||||||||||||||||||||||||||
Results are expressed as mean ± SEM. , as compared to NC group; , as compared to AC group. NNot significant as compared to AC group. |